That's a very good question, and I'm glad you asked it so I can clarify. All of our cohort had inhalation exposure at what we call time zero, at the time of impact. That just makes sense.
With the advance of science in the 20 years since the exposure took place, we have imaging techniques that have allowed us to look at pulmonary lymph nodes, which is where some of the particulate that was inhaled might have been deposited or be hanging out. Although the vast majority of a burden of inhalation would be eliminated over time, it has been something that I have wanted to rule out, that there wasn't something sequestered in pulmonary lymph nodes. That's a good question.
When we did that we didn't see any hot spots in the pulmonary lymph nodes. Again, I hope that you folks and others who have read our papers would agree that if you are the subject of an impact and an inhalation of an explosion with DU, you are the most highly exposed population. We don't have any non-Hodgkin's lymphomas in our cohort.
Again, on the radiation issue, non-Hodgkin's lymphoma has been linked to radiation exposure generally, but remember in the beginning of the hearing I mentioned that we really believe the primary toxicity of our veterans from exposure to depleted uranium is its chemical nature, not radiological.
Having said that, the inhalation of a radioactive particle would be the thing we'd want to watch for as a radiation risk, and maybe this goes to segue about the other elements of your committee's report and review. It's not just a review of the health outcomes that was done by your expert panel. It was the review of the exposure likelihood, the exposure opportunities. I hope your committee now looks at that as carefully as the review of the health outcomes, because if you don't have exposure, then even if there were health outcomes, they can't be attributed to depleted uranium.